Tanabe Research Laboratories USA Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tanabe Research Laboratories USA Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10796
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tanabe Research Laboratories USA Inc (Tanabe Research Laboratories USA), a subsidiary of Mitsubishi Tanabe Pharma Corp is a healthcare research center that discovers and develops biological drugs. The laboratory conducts research on metabolics, immunology and inflammation. Its products are used for the therapy of serious diseases with unmet needs. Tanabe Research Laboratories USA conducts antibody related research to target specific immune cells and soluble factors. The laboratory investigates new methods for modulating immune cell functions. It also works with academic research organizations and pharma, medical and healthcare companies. Tanabe Research Laboratories USA is headquartered in San Diego, California, the US.

Tanabe Research Laboratories USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AvantGen Partners with Tanabe Research Laboratories USA 10
Licensing Agreements 11
Tanabe Research Labs Enters into a Licensing Agreement with MedImmune 11
Covagen Enters Into Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 12
Covagen Expands Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 14
Tanabe Research Laboratories USA Inc – Key Competitors 16
Tanabe Research Laboratories USA Inc – Key Employees 17
Tanabe Research Laboratories USA Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Key Facts 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanabe Research Laboratories USA Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AvantGen Partners with Tanabe Research Laboratories USA 10
Tanabe Research Labs Enters into a Licensing Agreement with MedImmune 11
Covagen Enters Into Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 12
Covagen Expands Licensing Agreement With Mitsubishi Tanabe Pharma And Tanabe Research Labs 14
Tanabe Research Laboratories USA Inc, Key Competitors 16
Tanabe Research Laboratories USA Inc, Key Employees 17

List of Figures
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tanabe Research Laboratories USA Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Tanabe Research Laboratories USA Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Catalina Holdings (Bermuda) Ltd:企業のM&A・事業提携・投資動向
    Catalina Holdings (Bermuda) Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Catalina Holdings (Bermuda) Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • TMX Group Limited (X):企業の財務・戦略的SWOT分析
    TMX Group Limited (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SkyWest, Inc.:企業概要・SWOT・財務分析
    Summary Canadean's "SkyWest, Inc. : Travel and Tourism - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, co …
  • Bionure Farma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Bionure Farma SL (Bionure) is a healthcare service provider that provides treatment for ophthalmological diseases that concentrates on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment such as optic neuritis and neuromyelitis optica. Its lead ca …
  • Kobayashi Pharmaceutical Co Ltd (4967)-医療機器分野:企業M&A・提携分析
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …
  • Pernix Therapeutics Holdings, Inc.:企業のM&A・提携・投資分析
    Pernix Therapeutics Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pernix Therapeutics Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Option NV (OPTI):企業の財務・戦略的SWOT分析
    Option NV (OPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BIONIME Corporation (4737):企業概要、財務及び戦略的SWOT分析
    Summary BIONIME Corporation (BIONIME) is a medical device company. The company commercializes self monitoring blood glucose system for biotechnology and medical testing industry. Its products include GM100 series, GM300 series, GM210 series, GM550 series, GM700 series, GS300 test strip, GS100 test s …
  • Fundación Bancaria Caixa d’Estalvis i Pensions de Barcelona, “la Caixa” (CABK):企業のM&A・提携動向(エネルギー分野)
    Summary Fundación Bancaria Caixa d’Estalvis i Pensions de Barcelona, "la Caixa" (la Caixa), formerly Caixa D’Estalvis I Pensions De Barcelona, is an independent, privately held, nonprofit, charitable and social institution whose founding objective is to promote and carry out social, welfare, assista …
  • Novo Nordisk A/S:企業のM&A・提携・投資分析
    Novo Nordisk A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novo Nordisk A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Evergreen Fibreboard Berhad:企業の戦略・SWOT・財務情報
    Evergreen Fibreboard Berhad - Strategy, SWOT and Corporate Finance Report Summary Evergreen Fibreboard Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Rexahn Pharmaceuticals Inc (RNN):企業財務及び戦略的SWOT分析
    Summary Rexahn Pharmaceuticals Inc (Rexahn Pharmaceuticals) formerly Corporate Road Show.com Inc., is a clinical stage biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutics for the treatment of cancer. The company’s anti-cancer drug candidates inc …
  • Enzymotec Ltd:企業の戦略・SWOT・財務情報
    Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report Summary Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Align Technology, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Align Technology, Inc. Mergers …
  • AdvantEdge Healthcare Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Saab AB:企業のM&A・提携・投資分析
    Saab AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Saab AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Hengan International Group Company Limited (1044):企業概要、財務及び戦略的SWOT分析
    Summary Hengan International Group Company Limited (Hengan International) is a sanitary products manufacturer. The company manufactures, distributes and sells personal hygiene products. Its products include sanitary napkins, pantiliners, skincare wipes, baby diapers, adult diapers, box tissue papers …
  • Hazama Ando Corporation:企業の戦略・SWOT・財務情報
    Hazama Ando Corporation - Strategy, SWOT and Corporate Finance Report Summary Hazama Ando Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hydromer, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hydromer, Inc. Mergers and Acqu …
  • Ford Motor Company:戦略・SWOT・企業財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆